Back to Journals » Journal of Blood Medicine » Volume 1 » default

Journal of Blood Medicine
- View all (272)
- Volume 10, 2019 (48)
- Volume 9, 2018 (30)
- Volume 8, 2017 (24)
- Volume 7, 2016 (30)
- Volume 6, 2015 (31)
- Volume 5, 2014 (27)
- Volume 4, 2013 (21)
- Volume 3, 2012 (19)
- Volume 2, 2011 (18)
- Volume 1, 2010 (24)
Archive: Volume 1, 2010

Efficacy of dasatinib for the treatment of intractable chronic myeloid leukemia
Lisa M Lima, Martha Arellano, Stacie Holloway, et al
Journal of Blood Medicine 2010, 1:221-225
Published Date: 10 September 2010

Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor
Kade Birkeland, David Parra, Robert Rosenstein
Journal of Blood Medicine 2010, 1:197-219
Published Date: 1 September 2010

Treatment of hemophilia: a review of current advances and ongoing issues
Antonio Coppola, Mirko Di Capua, Matteo Nicola Dario, et al.
Journal of Blood Medicine 2010, 1:183-195
Published Date: 30 August 2010

Myelodysplastic syndromes/neoplasms: recent classification system based on World Health Organization Classification of Tumors – International Agency for Research on Cancer for Hematopoietic and Lymphoid Tissues
Geetanjali Gupta, Reecha Singh, Dhananjay S Kotasthane, et al
Journal of Blood Medicine 2010, 1:171-182
Published Date: 25 August 2010

Cinryze™ as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety
Michael Lunn, Carah Santos, Timothy Craig
Journal of Blood Medicine 2010, 1:163-170
Published Date: 24 August 2010

Vascular nitric oxide: formation and function
Richard C Jin, Joseph Loscalzo
Journal of Blood Medicine 2010, 1:147-162
Published Date: 13 August 2010

ABO and rhesus blood group distribution in Kurds
Mohamad S Jaff
Journal of Blood Medicine 2010, 1:143-146
Published Date: 10 August 2010

Thrombin use in surgery: an evidence-based review of its clinical use
Sung W Ham, Wesley K Lew, Fred A Weaver
Journal of Blood Medicine 2010, 1:135-142
Published Date: 22 July 2010

Homocysteine and folate levels as indicators of cerebrovascular accident
VO Osunkalu, AT Onajole, KA Odeyemi, et al
Journal of Blood Medicine 2010, 1:131-134
Published Date: 14 July 2010

Emerging antithrombotic agents for thromboprophylaxis, clinical potential and patient considerations
Lars C Borris
Journal of Blood Medicine 2010, 1:123-130
Published Date: 5 July 2010

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)
Aref Al-Kali, William Wierda, Michael Keating, et al
Journal of Blood Medicine 2010, 1:115-122
Published Date: 21 June 2010

Use of sulodexide in patients with peripheral vascular disease
J Lasierra-Cirujeda, P Coronel, MJ Aza, et al
Journal of Blood Medicine 2010, 1:105-114
Published Date: 15 June 2010

L-CBM signaling in lymphocyte development and function
Hiromitsu Hara, Eiichi IIzasa, Mako Nakaya, et al
Journal of Blood Medicine 2010, 1:93-104
Published Date: 4 June 2010

Emerging antiplatelet agents, differential pharmacology, and clinical utility
Pranab Das, Carrie S Oliphant, Elizabeth Beach, et al
Journal of Blood Medicine 2010, 1:79-91
Published Date: 31 May 2010

Blood lead in the 21st Century: The sub-microgram challenge
Maria A Amaya, Kevin W Jolly, Nicholas E Pingitore Jr
Journal of Blood Medicine 2010, 1:71-78
Published Date: 3 June 2010

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
Gianluca Campo, Luca Fileti, Marco Valgimigli, et al
Journal of Blood Medicine 2010, 1:61-69
Published Date: 10 May 2010

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
Paola Ferrazzi, Anna Colombo, Pierpaolo Di Micco, et al
Journal of Blood Medicine 2010, 1:57-60
Published Date: 3 May 2010

A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin’s lymphomas
Chitra Hosing, Mark F Munsell, James M Reuben, et al
Journal of Blood Medicine 2010, 1:49-55
Published Date: 14 April 2010

Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors
Ampaiwan Chuansumrit, Pantep Angchaisuksiri, Nongnuch Sirachainan
Journal of Blood Medicine 2010, 1:37-48
Published Date: 30 March 2010

Solitary plasmacytoma of the jaw
Serena Marotta, Pierpaolo Di Micco
Journal of Blood Medicine 2010, 1:33-36
Published Date: 30 March 2010

A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonists
Meaghan Khan, Joseph Mikhael
Journal of Blood Medicine 2010, 1:21-31
Published Date: 23 March 2010

Homeostatic and pathogenic extramedullary hematopoiesis
Chang H Kim
Journal of Blood Medicine 2010, 1:13-19
Published Date: 23 March 2010

Venous thromboembolism and pregnancy
Maristella D’Uva, Pierpaolo Di Micco, Ida Strina, et al
Journal of Blood Medicine 2010, 1:9-12
Published Date: 3 March 2010

The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies
Jorge Castillo, Kimberly Perez
Journal of Blood Medicine 2010, 1:1-8
Published Date: 25 February 2010